Joydeep Goswami's Planned Sale of Biolife Solutions Inc. Common Stock

Joydeep Goswami, a director at Biolife Solutions Inc., has filed a Form 144 notice indicating his intention to sell 9,000 shares of common stock. The shares were acquired as compensation between August 9, 2022, and May 6, 2023. The planned sale is scheduled for October 16, 2025, with an aggregate market value of $278,910. The shares will be sold through The Charles Schwab Corporation. No securities were sold in the past three months. The filing highlights the director's financial transactions and provides transparency regarding the planned sale of securities.